Clinical Trials Directory

Trials / Unknown

UnknownNCT03797742

A Clinical Follow-up Study of Heart Failure Patients.

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Shanghai Zhongshan Hospital · Academic / Other
Sex
All
Age
15 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Heart failure (HF), a current worldwide pandemic with an unacceptable high level of morbidity and mortality, brings an enormous medical and societal burden. Chronic HF is characterized by progressive alteration of cardiac structure and function. But the molecular mechanism of these alterations is still not well-established and needs to be discussed further. HF is a highly heterogeneous disease that can be caused by a multiple of diseases. Dilated cardiomyopathy (DCM) and ischemic cardiomyopathy (ICM) are the main causes of this syndrome. Although HF is the common manifestation of DCM and ICM, the etiology and pathogenesis are different. Understanding the different pathophysiological mechanisms will contribute to the prevention and individualized therapy of heart failure. Therefore, this study aims to observation the different characteristics of the molecular biology and clinical courses in DCM and ICM patients.

Conditions

Timeline

Start date
2018-01-01
Primary completion
2022-12-01
Completion
2022-12-01
First posted
2019-01-09
Last updated
2019-01-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03797742. Inclusion in this directory is not an endorsement.

A Clinical Follow-up Study of Heart Failure Patients. (NCT03797742) · Clinical Trials Directory